EBENEZERBusiness
eGenesis is developing genome-engineered organs aimed at addressing the global shortage of transplantable organs and improving treatment options for patients suffering from organ failure.
Read full story on The Hindu →
India — The Hindu
eGenesis is developing genome-engineered organs aimed at addressing the global shortage of transplantable organs and improving treatment options for patients suffering from organ failure.
This report is published with credit to The Hindu. The wire sent a summary; open the original for any extra context. Read on The Hindu →
Source: The Hindu. Published 25 Aug 2026, 12:56 pm.
Most relevant
It would be one of Air India’s largest publicly reported requests for shareholder funding since Tata took control of the former state-owned carrier in 2022
Read on The Hindu →Editor’s choice
Spot gold touches almost $4,700 an ounce and Bitcoin tops $80,000 while oil prices fall despite threat of heavy US sanctions on Iran and any country trading with it
Read on theguardian.com →